BioWorld

Feb. 22, 2010

View Archived Issues

Psychiatric Drug Safety Test: New Wave in Predictive Push

Read More

Pharma, Generics Firms See More Green on the Other Side

Cephalon Inc.'s recent $590 million purchase of Swiss generics player Mepha AG was intended to create a balanced portfolio of branded products and generics. Read More

Money Raised By Biotech in 2010

Read More

The Mod 'Quad': Gilead's Pill Could Plant Next Flag in HIV

Read More

Money Raised Year to Date

Read More

Week in Review

Read More

Word on the Street

Read More

Week in Washington

Read More

Biotechnology Company Deals With Other Biotechnology Companies: Dec. 1, 2009 - Feb. 18, 2010

Read More

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Dec. 1, 2009 - Feb. 18, 2010

Read More

Biotech-Biotech Collaborations: Modified Agreements: Dec. 1, 2009 - Feb. 18, 2010

Read More

Biotech Collaborations And Other Actions In Agriculture And Animals: Jan. 1 - Dec. 31, 2009

Read More

Stock Gainers and Losers For The Week

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More